Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen in the Breast International Group (BIG) 1-98 trial

被引：0
|
作者：
Ribi, K. E. [1 ]
Phillips, K. A. [1 ]
Sun, Z. [1 ]
Stephens, A. [1 ]
Thompson, A. [1 ]
Harvey, V. [1 ]
Thuerlimann, B. [1 ]
Cardoso, F. [1 ]
Coates, A. S. [1 ]
Bernhard, J. [1 ]
机构：
[1] IBCSG, BIG1 98 Collaborat Grp, Bern, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
510
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial
    Phillips, Kelly-Anne
    Ribi, Karin
    Sun, Zhuoxin
    Stephens, Alisa
    Thompson, Alastair
    Harvey, Vernon
    Thuerlimann, Beat
    Cardoso, Fatima
    Pagani, Olivia
    Coates, Alan S.
    Goldhirsch, Aron
    Price, Karen N.
    Gelber, Richard D.
    Bernhard, Juerg
    BREAST, 2010, 19 (05): : 388 - 395
  • [2] Changes in cognitive function in postmenopausal women 1 year after completing adjuvant letrozole or tamoxifen in the Breast International Group (BIG) 1-98 trial.
    Ribi, K.
    Aldridge, J.
    Phillips, K.
    Sun, Z.
    Thompson, A. M.
    Harvey, V. J.
    Thuerlimann, B.
    Cardoso, F.
    Coates, A. S.
    Bernhard, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
    Phillips, Kelly-Anne
    Aldridge, Julie
    Ribi, Karin
    Sun, Zhuoxin
    Thompson, Alastair
    Harvey, Vernon
    Thuerlimann, Beat
    Cardoso, Fatima
    Pagani, Olivia
    Coates, Alan S.
    Goldhirsch, Aron
    Price, Karen N.
    Gelber, Richard D.
    Bernhard, Juerg
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (01) : 221 - 226
  • [4] Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
    Kelly-Anne Phillips
    Julie Aldridge
    Karin Ribi
    Zhuoxin Sun
    Alastair Thompson
    Vernon Harvey
    Beat Thürlimann
    Fatima Cardoso
    Olivia Pagani
    Alan S. Coates
    Aron Goldhirsch
    Karen N. Price
    Richard D. Gelber
    Jürg Bernhard
    Breast Cancer Research and Treatment, 2011, 126 : 221 - 226
  • [5] Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial
    Ewertz, Marianne
    Gray, Kathryn P.
    Regan, Meredith M.
    Ejlertsen, Bent
    Price, Karen N.
    Thuerlimann, Beat
    Bonnefoi, Herve
    Forbes, John F.
    Paridaens, Robert J.
    Rabaglio, Manuela
    Gelber, Richard D.
    Colleoni, Marco
    Lang, Istvan
    Smith, Ian E.
    Coates, Alan S.
    Goldhirsch, Aron
    Mouridsen, Henning T.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (32) : 3967 - 3975
  • [6] Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
    Regan, Meredith M.
    Price, Karen N.
    Giobbie-Hurder, Anita
    Thuerlimann, Beat
    Gelber, Richard D.
    BREAST CANCER RESEARCH, 2011, 13 (03)
  • [7] Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
    Meredith M Regan
    Karen N Price
    Anita Giobbie-Hurder
    Beat Thürlimann
    Richard D Gelber
    Breast Cancer Research, 13
  • [8] 12 years' median follow up (MFU) of BIG 1-98: Adjuvant letrozole, tamoxifen and their sequence for postmenopausal women with endocrine responsive early breast cancer
    Thuerlimann, B.
    Giobbie-Hurder, A.
    Colleoni, M.
    Jensen, M-B
    Ejlertsen, B.
    de Azambuja, E.
    Neven, P.
    Lang, I.
    Gladieff, L.
    Bonnefoi, H.
    Harvey, V. J.
    Spazzapan, S.
    Tondini, C.
    Price, K.
    Piccart-Gebhart, M.
    Regan, M. M.
    Gelber, R. D.
    Coates, A. S.
    Goldhirsch, A.
    CANCER RESEARCH, 2017, 77
  • [9] Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences
    DeCensi, Andrea
    Sun, Zhuoxin
    Guerrieri-Gonzaga, Aliana
    Thuerlimann, Beat
    McIntosh, Christina
    Tondini, Carlo
    Monnier, Alain
    Campone, Mario
    Debled, Marc
    Schoenenberger, Astrid
    Zaman, Khalil
    Johansson, Harriet
    Price, Karen N.
    Gelber, Richard D.
    Goldhirsch, Aron
    Coates, Alan S.
    Aebi, Stefan
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (02) : 321 - 329
  • [10] Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences
    Andrea DeCensi
    Zhuoxin Sun
    Aliana Guerrieri-Gonzaga
    Beat Thürlimann
    Christina McIntosh
    Carlo Tondini
    Alain Monnier
    Mario Campone
    Marc Debled
    Astrid Schönenberger
    Khalil Zaman
    Harriet Johansson
    Karen N. Price
    Richard D. Gelber
    Aron Goldhirsch
    Alan S. Coates
    Stefan Aebi
    Breast Cancer Research and Treatment, 2014, 144 : 321 - 329
12345